LG Chem

AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee

Retrieved on: 
Thursday, March 28, 2024
Novartis, Acute lymphoblastic leukemia, Head, LG, Translational research, Urology, Oncology, Drug discovery, Executive, LG Chem, Lung, Anschutz Medical Campus, Committee, SRL Diagnostics, University, Laboratory, Doctor of Philosophy, RWTH Aachen University, Senior, Radiopharmaceutical, European Medicines Agency, ARUP Laboratories, Therapy, Drug development, Pharmacology, Pharmaceutical industry

BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer. Dr. Braendle is a life sciences executive with experience spanning from early drug discovery to the launch of small molecules, biologics, radiopharmaceuticals, gene and cell therapies, and medical device development.

Key Points: 
  • BOSTON, March 25, 2024 (GLOBE NEWSWIRE) -- AVEO Oncology (“AVEO”), an LG Chem company, today announced the appointment of Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer.
  • “We are delighted to have Dr. Braendle join the AVEO Oncology team particularly at this important juncture as we seek to become a global top 20 oncology leader,” said Michael P. Bailey, President and Chief Executive Officer of AVEO Oncology, an LG Chem company.
  • Today, AVEO Oncology, an LG Chem company, and LG Chem Life Sciences also announced the formation of its Scientific Advisory Committee (“Committee”).
  • The Scientific Advisory Committee is comprised of several leading cancer experts, including:
    Professor and Deputy Chair for Translational Research, Department of Gastrointestinal Medical Oncology
    University of Colorado Cancer Center, Aurora

Semiconductor & IC packaging materials Market worth $70.9 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, March 25, 2024
Polychlorinated biphenyl, Growth, Kyocera, IC, Amkor Technology, Internet of things, LG Chem, Tablet, Electronics, AI, Texas Instruments, SOP, SMT, PCB, Ceramic

They also offer robust protection against environmental factors like moisture and mechanical stress, ensuring the durability and reliability of semiconductor devices.

Key Points: 
  • They also offer robust protection against environmental factors like moisture and mechanical stress, ensuring the durability and reliability of semiconductor devices.
  • In essence, the amalgamation of compactness, high pin density, SMT compatibility, thermal management capabilities, versatility, and excellent electrical performance positions SOP technology as the preferred choice in the semiconductor and IC packaging materials market.
  • Additionally, rapid innovation in technologies such as AI, AR, and IoT requires packaging materials supporting high-speed data processing and thermal management.
  • This sector heavily relies on semiconductor and IC packaging materials for a wide array of products including smartphones, laptops, wearables, and automotive electronics.

Semiconductor & IC packaging materials Market worth $70.9 billion by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Monday, March 25, 2024
Polychlorinated biphenyl, Growth, Kyocera, IC, Amkor Technology, Internet of things, LG Chem, Tablet, Electronics, AI, Texas Instruments, SOP, SMT, PCB, Ceramic

They also offer robust protection against environmental factors like moisture and mechanical stress, ensuring the durability and reliability of semiconductor devices.

Key Points: 
  • They also offer robust protection against environmental factors like moisture and mechanical stress, ensuring the durability and reliability of semiconductor devices.
  • In essence, the amalgamation of compactness, high pin density, SMT compatibility, thermal management capabilities, versatility, and excellent electrical performance positions SOP technology as the preferred choice in the semiconductor and IC packaging materials market.
  • Additionally, rapid innovation in technologies such as AI, AR, and IoT requires packaging materials supporting high-speed data processing and thermal management.
  • This sector heavily relies on semiconductor and IC packaging materials for a wide array of products including smartphones, laptops, wearables, and automotive electronics.

Surging EV Sales and Advanced Energy Storage Fuel 12.4% Growth in Lithium-Ion Battery Dispersant Market

Retrieved on: 
Thursday, March 21, 2024
Lithium, Projection, Lignosulfonates, Environment, Tennessee State University, Associate, LG Chem, Toyota, Carbon, Traction, Ecosystem

NEWARK, Del., March 21, 2024 /PRNewswire/ -- FMI predict, the global lithium-ion battery dispersant market was valued at US$ 826.1 million in 2023 and is anticipated to attain a valuation of US$ 3045 million by 2034. The market is likely to develop at a 12.4% CAGR from 2024 to 2034, reaching a valuation of US$ 949.2 million in 2024.

Key Points: 
  • The United States lithium-ion battery dispersant ecosystem is poised to develop at a CAGR of 12.6% over the projection period.
  • By end use, lithium ion battery dispersant will widely be used in the consumer electronics sector, with a 12% CAGR from 2024 to 2034.
  • Purchase now and gain full access to the Lithium-ion Battery Dispersant Industry report, featuring comprehensive Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives.
  • Future Market Insights offers an unbiased analysis of the lithium-ion battery dispersant market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

Surging EV Sales and Advanced Energy Storage Fuel 12.4% Growth in Lithium-Ion Battery Dispersant Market

Retrieved on: 
Thursday, March 21, 2024
Lithium, Projection, Lignosulfonates, Environment, Tennessee State University, Associate, LG Chem, Toyota, Carbon, Traction, Ecosystem

NEWARK, Del., March 21, 2024 /PRNewswire/ -- FMI predict, the global lithium-ion battery dispersant market was valued at US$ 826.1 million in 2023 and is anticipated to attain a valuation of US$ 3045 million by 2034. The market is likely to develop at a 12.4% CAGR from 2024 to 2034, reaching a valuation of US$ 949.2 million in 2024.

Key Points: 
  • The United States lithium-ion battery dispersant ecosystem is poised to develop at a CAGR of 12.6% over the projection period.
  • By end use, lithium ion battery dispersant will widely be used in the consumer electronics sector, with a 12% CAGR from 2024 to 2034.
  • Purchase now and gain full access to the Lithium-ion Battery Dispersant Industry report, featuring comprehensive Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives.
  • Future Market Insights offers an unbiased analysis of the lithium-ion battery dispersant market, providing historical data for 2019 to 2022 and forecast statistics from 2023 to 2033.

Gevo Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, March 7, 2024
Carbon, Engineering, Inflation, LG Chem, Depreciation, Research, Aviation, Renewable natural gas, LCFS, British thermal unit, Investment, Farmer, Growth, Sale, GEVO, SAF, GAAP, Interest, Plastic, Department of the Treasury, Agriculture, Treasury, Workforce, USDA, Ethanol, RNG, Cryptocurrency

ENGLEWOOD, Colo., March 07, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the fourth quarter and full year 2023 and recent corporate highlights.

Key Points: 
  • ENGLEWOOD, Colo., March 07, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the fourth quarter and full year 2023 and recent corporate highlights.
  • Net-Zero 1 and 2024 Expected Uses of Cash: We ended the fourth quarter with cash, cash equivalents, and restricted cash of $375.6 million.
  • Verity: In the third quarter of 2023, our Verity Tracking platform went live with farmers in South Dakota and Minnesota.
  • Gevo NW Iowa RNG generated positive, stand-alone non-GAAP cash EBITDA1 of $1.3 million for the fourth quarter.

Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update

Retrieved on: 
Thursday, February 22, 2024
EMANATE, New Drug Application, Investment, Obesity, BMI, Webcast, Initiate, BBS, Stage 2, Hyperpigmentation, Documentation, Polyphagia, European, GAAP, European Medicines Agency, PCSK1, Type, Type 2, G&A, LG Chem, BV, Completeness, Shanda, Bardet–Biedl syndrome, Clinical trial, LEPR, Medicaid, IND, Prescription, Research, Hunger, Acquisition, Quarter, EMA, MC4R, FDA, Prevalence, PMDA, Patient, POMC, Body mass index, Pharmaceutical industry

-- Acquired global rights to oral MC4R agonist LB54640 from LG Chem --

Key Points: 
  • ET --
    BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2023.
  • Fourth Quarter and Full Year 2023 Financial Results:
    Cash Position: As of December 31, 2023, cash, cash equivalents and short-term investments were approximately $275.8 million, as compared to $333.3 million as of December 31, 2022.
  • S,G&A Expenses: S,G&A expenses were $32.4 million in the fourth quarter of 2023 and $117.5 million for the year ended December 31, 2023, compared to $26.3 million in the fourth quarter of 2022 and $92.0 million for the year ended December 31, 2022.
  • ET today to review its fourth quarter and year end 2023 financial results and recent business activities.

NPE2024 Will Be The Largest Gathering of Bioplastics Companies In The Americas

Retrieved on: 
Tuesday, February 20, 2024
Manufacturing, Environment, Recycling, Sustainability, Chemicals, Plastics, Collection, LG Chem, NatureWorks, NPE, Plastic, Growth, Orange County Convention Center, Krieger, Safety, LyondellBasell, Policy

The Plastics Industry Association (PLASTICS) will foster the continued growth of the bioplastics industry at its upcoming trade show, NPE: The Plastics Show .

Key Points: 
  • The Plastics Industry Association (PLASTICS) will foster the continued growth of the bioplastics industry at its upcoming trade show, NPE: The Plastics Show .
  • With more than 45 bioplastics related exhibitors on the show floor, NPE2024 is expected to be the largest gathering of bioplastics companies in the Americas.
  • NPE2024 will provide a first-hand look into how sustainable plastics manufacturing is driving value creation for society, the environment and the industry.
  • Additionally, made for plastic material suppliers, processors, equipment suppliers, and brands interested in investing in the bioplastics industry, PLASTICS will release it’s 2024 Bioplastics Market Watch Report on May 8 during NPE.

AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist

Retrieved on: 
Tuesday, February 6, 2024
OS, Vanderbilt-Ingram Cancer Center, VEGFR, Survival, IO, TKI, Renal cell carcinoma, Division, RCC, MD, PFS, Safety, Patient, Progression-free survival, Sorafenib, Arm, Disease, ITT, Assistant, Oncology, LG Chem, Doctor of Philosophy, Pharmaceutical industry

The trial included a predefined subgroup of patients (26%) who were previously treated with both an immuno-oncology (IO) therapy and a VEGFR TKI.

Key Points: 
  • The trial included a predefined subgroup of patients (26%) who were previously treated with both an immuno-oncology (IO) therapy and a VEGFR TKI.
  • “For patients with relapsed or refractory advanced renal cell carcinoma, long-term progression-free survival is a vital measure of the value of anticancer therapy,” commented Michael Bailey, President and CEO of AVEO Oncology.
  • The trial randomized 350 patients to receive FOTIVDA (1.5 mg once daily) or sorafenib (400 mg twice daily).
  • The intent-to-treat (ITT) population included 175 patients in each arm; the safety population included 173 patients in the FOTIVDA arm and 170 in the sorafenib arm.

Mobile Robots Market (AGV and AMR) to reach ~$20B TAM by 2028 with an installed base of 2,700,000 Mobile Robots - LogisticsIQ

Retrieved on: 
Wednesday, January 31, 2024
Clearpath Robotics, CSG, Wireless, Musiktheater im Revier, JBT Corporation, ASP, Viastore Systems, Crown Equipment Corporation, QR, AMR, Software, Sensor fusion, SoftBank Group, Robert Williams (robot fatality), Safety, Human voice, KION Group, Informatik, Hikvision, Rockwell Automation, MOV, FREEDOM, Artificial intelligence, CPM, Beumer Group, JD, Growth, Robotics, Honeywell Intelligrated, Gesellschaft mit beschränkter Haftung, SBS, Deep learning, OPEX, KUKA, ROI, Automation, CGI, Vecna Robotics, OPEX (corporation), LG Chem, RaaS, ST Engineering, Mobile industrial robots, TAM, DMW, Omron Adept, ASRS, AI, Research, MHS, QR code, Security, Motion control, ASI, Bossa Nova Robotics, Lidar, EnerSys, Ocado, PSB, Mobile robot, AGV, Communication, Retail

Both AGVs and AMRs collectively are going to cross the installed base of 2.7 million units in 2028 to make the mobile robots a new normal in our day-to-day operational activities.

Key Points: 
  • Both AGVs and AMRs collectively are going to cross the installed base of 2.7 million units in 2028 to make the mobile robots a new normal in our day-to-day operational activities.
  • United States, Germany, U.K., and China are going to lead the market with an annual demand of more than 350,000 mobile robots (AGV & AMR) by 2028.
  • Goods to Person (G2P) and Person to Goods (P2G), both type of AMRs are having their own market with some advantages and disadvantage.
  • Picking Robots, Manipulator Robots, Case Handling Robots, and Sortation Robots are going to emerge as a new important category by 2028, specially in micro-fulfillment space.